Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Feb 28;103(9):3135-40.
doi: 10.1073/pnas.0511264103. Epub 2006 Feb 21.

Homodimeric cross-over structure of the human granulocyte colony-stimulating factor (GCSF) receptor signaling complex

Affiliations

Homodimeric cross-over structure of the human granulocyte colony-stimulating factor (GCSF) receptor signaling complex

Taro Tamada et al. Proc Natl Acad Sci U S A. .

Abstract

A crystal structure of the signaling complex between human granulocyte colony-stimulating factor (GCSF) and a ligand binding region of GCSF receptor (GCSF-R), has been determined to 2.8 A resolution. The GCSF:GCSF-R complex formed a 2:2 stoichiometry by means of a cross-over interaction between the Ig-like domains of GCSF-R and GCSF. The conformation of the complex is quite different from that between human GCSF and the cytokine receptor homologous domain of mouse GCSF-R, but similar to that of the IL-6/gp130 signaling complex. The Ig-like domain cross-over structure necessary for GCSF-R activation is consistent with previously reported thermodynamic and mutational analyses.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: No conflicts declared.

Figures

Fig. 1.
Fig. 1.
Overall structure of the 2:2 complex between hGCSF and hGCSF-R (Ig–CRH domain). The GCSF molecules are colored in red and orange, and GCSF-R molecules are colored in green and cyan. Fig. 1 was prepared by the pymol Molecular Graphics System (DeLano Scientific, San Carlos, CA).
Fig. 2.
Fig. 2.
Amino acid sequence alignments between ligands (hGCSF, hIL-6, and vIL-6) (a) and Ig-CRH domains of human receptors (GCSF-R and gp130) (b). The sequence identity between GCSF and IL-6 is 18%, and the identity between the Ig–CRH domains of hGCSF-R and human gp130 is 29%. The secondary structure elements [helices and strands; calculated by procheck (35)] are also shown as wavy (cyan) and solid (purple) lines, respectively. Identical amino acid residues are shaded in black. The residues concerned with ligand–receptor binding at sites I, II, and III are colored by green, red, and blue, respectively. Asterisks and pluses show binding sites at site II of gp130 in hIL-6 and vIL-6 complex, respectively. Structurally disordered regions are shown as gray. Three free cysteines, which are colored yellow, in Ig–CRH domains of GCSF-R are mutated to serines in this study.
Fig. 3.
Fig. 3.
Close-up view of the interface between ligand and receptor. (a) Site II. (b) Site III. Related residues of ligand–receptor binding are drawn as stick model. Figs. 3–5 were prepared by weblab viewer lite (Accelrys Inc., San Diego).
Fig. 4.
Fig. 4.
The 2:2 conformation between ligand and receptor. (a) hGCSF and hGCSF-R (Ig–CRH domain). (b) hGCSF and mouse GCSF-R (CRH domain). (c) hIL-6, human gp130 (Ig–CRH domain), and hIL-6Rα. (d) vIL-6 and human gp130. Ligands are colored in red and orange. Receptors are colored in green and cyan. The IL-6Rα molecules are drawn by wire model. Dashed lines and ellipse show twofold axis.
Fig. 5.
Fig. 5.
Structural comparison of GCSF-R complex and gp130 complex. (a) Site II. (b) Site III. Complexes are superimposed in a and separated in b. The GCSF, GCSF-R, IL-6, and gp130 molecules are colored in red, green, cyan, and orange, respectively. Related residues of specificity are drawn by stick model.

References

    1. Nagata S., Tsuchiya M., Asano S., Kaziro Y., Yamazaki T., Yamamoto O., Hirata Y., Kubota N., Oheda M., Nomura H., et al. Nature. 1986;319:415–418. - PubMed
    1. Metcalf D. Nature. 1990;339:27–30. - PubMed
    1. Welte K., Gabrilove J., Bronchud M. H., Platzer E., Morstyn G. Blood. 1996;88:1907–1929. - PubMed
    1. Fukunaga R., Ishizaka-Ikeda E., Seto Y., Nagata S. Cell. 1990;61:341–350. - PubMed
    1. Fukunaga R., Seto Y., Mizushima S., Nagata S. Proc. Natl. Acad. Sci. USA. 1990;87:8702–8706. - PMC - PubMed

Publication types

MeSH terms

Substances

Associated data